We are proud to announce that we have been awarded the Take-Off 2 Grant of €450K! This is an important recognition of the progress of the company and the potential of our technology! This grant enables us to take the next steps in growing the company and further accelerate our plans. With this grant we will refine and validate our technology, start setting up pilot tests and prepare for broad implementation. This funding marks an important step in bringing this technology to

On November 6th, Respira Technology participated in the Medtech Meeting, where we presented the potential of breath-based biomarker detection and discussed the broader applicability of our technology. The primary focus of Respira is the detection of nitrous oxide (laughing gas). We currently have a working prototype and are progressing rapidly in the development and validation of this technology. At the same time, we are exploring the detection of additional breath biomarkers

We are very proud to announce that Respira has won the prestigious Amsterdam Science and Innovation Awards organised by IXA in the...

Pepijn van Rutten was guest at BNR news radio to talk about Respira. In an interesting talk with Karlijn Meinders, we spoke about the...